MTAP and neoplasm: For example, frequent deletion of the enzyme methylthioadenosine phosphorylase (MTAP), due to its proximity to p16/CDKN2A tumor-suppressor gene, results in accumulation of the metabolite MTA, which significantly reduces the activity of PRMT5 methyltransferase, thereby creating a therapeutic opportunity45–47.